Remove 2017 Remove Clinical Trials Remove Data
article thumbnail

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain.

article thumbnail

Tilray marks milestone German cannabis harvest and launches medical prescriptions drive

Cannabis Law Report

The country, which Tilray said has an estimated medical marijuana demand of more than 100,000 patients, legalized the drug for medical use in 2017 but has since relied on importing it. We do believe that there is an important role for clinical trials to play in terms of establishing the efficacy of the product,” Faltischek said. “We

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pain Relief: Marijuana vs. Opioids

CannaMD

In addition, data from the 2017 National Survey on Drug Use and Health showed a potential inverse relationship between marijuana and opioid use, based on data that reported a drop of opioid misuse from 2016 to 2017 (from 11.8 million to 11.4

Marijuana 107
article thumbnail

Cannabis Helps, Say Over Half of Parkinson’s Patients Who Use It

The Cannigma

Medical cannabis was legally approved in Germany in 2017 when approval was given for therapy-resistant symptoms in severely affected patients independent of diagnosis and without clinical evidence-based data,” lead investigator Professor Carsten Buhmann of the University Medical Center Hamburg-Eppendorf explained in a statement.

article thumbnail

CBD Market Report

Project CBD

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. million more on CBD products in 2021 compared to 2017 — a 413.4%

CBD 144
article thumbnail

Pharmadrug Announces Positive Research Results of Cepharanthine to Treat Multiple Cancers

Cannabis Law Report

The results also provide confidence in the Company’s plan to dedicate resources to advance PD-001 through FDA IND-enabling studies to support Phase 1 and 2 clinical studies. Previously the Company announced that it had secured FDA Orphan Drug Designation for cepharanthine in the treatment of esophageal cancer. ” Next Steps.

article thumbnail

Medical cannabis studies offer hope to opioid users

Healer

A 2017 review of existing studies by researchers Suzanna Nielsen of Australia’s University of New South Wales and Michael Farrell of the country’s National Drug and Alcohol Research Centre suggested that when co-administered with opioids, cannabis may enable reduced opioid doses without decreasing the pain relief. MAINE STUDY PROMISING.